Amundi
ELV icon

Amundi’s Elevance Health ELV Stock Holding History

Amundi’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$636M Sell
1,644,537
-1,049,127
-39% -$389M 0.15% 113
2026
Q1 		$789M Buy
2,693,664
+1,597,497
+146% +$525M 0.21% 81
2025
Q4 		$384M Sell
1,096,167
-26,632
-2% -$9M 0.1% 194
2025
Q3 		$393M Sell
1,122,799
-281,381
-20% -$87.5M 0.13% 141
2025
Q2 		$492M Buy
1,404,180
+320,023
+30% +$129M 0.17% 116
2025
Q1 		$491M Sell
1,084,157
-209,645
-16% -$84.2M 0.18% 119
2024
Q4 		$496M Sell
1,293,802
-38,706
-3% -$16.2M 0.17% 127
2024
Q3 		$652M Sell
1,332,508
-60,870
-4% -$32.5M 0.24% 95
2024
Q2 		$739M Buy
1,393,378
+29,896
+2% +$15.8M 0.28% 76
2024
Q1 		$715M Sell
1,363,482
-4,262
-0.3% -$2.12M 0.31% 74
2023
Q4 		$660M Sell
1,367,744
-144,889
-10% -$67M 0.3% 76
2023
Q3 		$685M Sell
1,512,633
-4,384
-0.3% -$1.99M 0.34% 62
2023
Q2 		$674M Sell
1,517,017
-328,596
-18% -$152M 0.34% 63
2023
Q1 		$895M Buy
1,845,613
+8,080
+0.4% +$3.85M 0.48% 36
2022
Q4 		$883M Buy
1,837,533
+524,419
+40% +$266M 0.48% 36
2022
Q3 		$629M Buy
1,313,114
+462,779
+54% +$221M 0.37% 50
2022
Q2 		$397M Sell
850,335
-325,389
-28% -$161M 0.32% 78
2022
Q1 		$605M Buy
1,175,724
+144,106
+14% +$65.9M 0.41% 50
2021
Q4 		$461M Sell
1,031,618
-56,662
-5% -$23.8M 0.29% 79
2021
Q3 		$406M Buy
1,088,280
+311,477
+40% +$118M 0.28% 76
2021
Q2 		$297M Buy
+776,803
New +$297M 0.21% 116

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Amundi's ELV Position: Q2 2026 in Review

Amundi reduced its Elevance Health (ELV) stake by 39% in Q2 2026, selling an estimated $389M and leaving 1,644,537 shares worth $636M. The position accounts for 0.15% of the portfolio, ranked #113.

Amundi first reported a position in ELV in Q2 2021 and has held it in 21 quarters since. The position peaked at $895M in Q1 2023. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Amundi held 1,644,537 shares of Elevance Health worth $636M as of Q2 2026.
  • Amundi sold 1,049,127 Elevance Health shares in Q2 2026, an estimated $389M.
  • Elevance Health made up 0.15% of Amundi's portfolio in Q2 2026, its #113 holding.
  • Amundi first reported a position in Elevance Health in Q2 2021 and has held it in 21 quarters since.
  • Amundi's Elevance Health position peaked at $895M in Q1 2023.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.